InsiderTrades.com logo
"This Could Be Worse Than the Great Depression, the Dot-Com Crash, and the 2008 Crisis Combined"
From Stansberry Research   |   Ad
What Are These Billionaire Investors Afraid Of? Billionaires Warren Buffett, Stanley Druckenmiller, George Soros, and David Tepper have all sold off massive U.S. stock positions, including shares of Nvidia, Apple, and Bank of America. Billionaire Ray Dalio, who runs one of the world’s most successful hedge funds, says, “Things are going to get worse for our economy.” What are these billionaires so worried about?
Click here to see why experts and insiders may be preparing for the biggest financial crisis of the

ALNY Insider Trading

Insider Ownership Percentage: 1.50%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $34,733,444.48

Alnylam Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Alnylam Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Alnylam Pharmaceuticals Share Price & Price History

Current Price: $250.98
Price Change: ▲ Price Increase of +6.09 (2.49%)
As of 11/26/2024 12:35 AM ET

This chart shows the closing price history over time for ALNY up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
"This Could Be Worse Than the Great Depression, the Dot-Com Crash, and the 2008 Crisis Combined"
From Stansberry Research   |   Ad
What Are These Billionaire Investors Afraid Of? Billionaires Warren Buffett, Stanley Druckenmiller, George Soros, and David Tepper have all sold off massive U.S. stock positions, including shares of Nvidia, Apple, and Bank of America. Billionaire Ray Dalio, who runs one of the world’s most successful hedge funds, says, “Things are going to get worse for our economy.” What are these billionaires so worried about?
Click here to see why experts and insiders may be preparing for the biggest financial crisis of the

Alnylam Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/20/2024Yvonne GreenstreetCEOSell15,000$280.00$4,200,000.0073,441View SEC Filing Icon  
8/6/2024Dennis A. AusielloDirectorSell20,250$262.00$5,305,500.00136View SEC Filing Icon  
8/1/2024Yvonne GreenstreetCEOSell15,148$270.00$4,089,960.0073,441View SEC Filing Icon  
7/11/2024Yvonne GreenstreetCEOSell7,093$261.00$1,851,273.0073,441View SEC Filing Icon  
6/25/2024Jeffrey V. PoultonCFOSell1,605$231.00$370,755.0028,892View SEC Filing Icon  
6/25/2024Kevin Joseph FitzgeraldEVPSell1,198$230.99$276,726.0214,181View SEC Filing Icon  
6/25/2024Pushkal GargCMOSell2,103$230.99$485,771.9715,609View SEC Filing Icon  
6/25/2024Yvonne GreenstreetCEOSell8,301$230.99$1,917,447.9980,534View SEC Filing Icon  
6/24/2024David E. I. PyottDirectorSell32,450$220.69$7,161,390.50136View SEC Filing Icon  
5/29/2024Amy W. SchulmanDirectorSell21,700$148.60$3,224,620.008,436View SEC Filing Icon  
12/27/2023Michael W. BonneyDirectorSell30,000$195.00$5,850,000.0016,029View SEC Filing Icon  
8/7/2023Pushkal GargCMOSell4,166$183.89$766,085.744,345View SEC Filing Icon  
8/4/2023Jeffrey V. PoultonCFOSell3,460$185.85$643,041.0015,873View SEC Filing Icon  
8/4/2023Pushkal GargCMOSell3,461$185.85$643,226.858,511View SEC Filing Icon  
8/4/2023Yvonne GreenstreetCEOSell4,057$185.85$753,993.4535,216View SEC Filing Icon  
4/27/2023Akshay VaishnawPresidentSell2,392$194.59$465,459.2817,890View SEC Filing Icon  
4/27/2023Jeffrey V. PoultonCFOSell977$194.59$190,114.4311,706View SEC Filing Icon  
4/27/2023Pushkal GargCMOSell1,839$194.59$357,851.016,800View SEC Filing Icon  
4/27/2023Tolga TangulerEVPSell1,476$194.59$287,214.841,801View SEC Filing Icon  
4/27/2023Yvonne GreenstreetCEOSell7,615$194.59$1,481,802.8530,332View SEC Filing Icon  
4/6/2023Indrani Lall FranchiniEVPSell3,500$210.00$735,000.00View SEC Filing Icon  
3/3/2023Pushkal GargCMOSell18,072$200.00$3,614,400.004,345View SEC Filing Icon  
2/2/2023Indrani Lall FranchiniEVPSell1,675$226.01$378,566.753,500View SEC Filing Icon  
8/5/2022Tolga TangulerEVPSell1,841$218.16$401,632.56View SEC Filing Icon  
8/3/2022Tolga TangulerEVPSell1,754$210.00$368,340.003,629View SEC Filing Icon  
7/5/2022Tolga TangulerEVPSell1,754$150.00$263,100.001,754View SEC Filing Icon  
4/1/2022Steven M. PaulDirectorSell15,000$170.69$2,560,350.001,000View SEC Filing Icon  
12/23/2021Akshay VaishnawInsiderSell2,879$190.93$549,687.47View SEC Filing Icon  
See Full Table
What Are Buffett, Dalio, and Druckenmiller So Worried About?
From Stansberry Research   |   Ad
"This Will Be Worse Than The Great Depression, The Dot-Com Crash, And The 2008 Crisis Combined" According to Dan Ferris, who has predicted nearly every major market crisis of the last 25 years, a new crisis in the US economy could soon cost you 50% of your portfolio or more if you don't prepare your wealth now. Especially if you’re sitting on large gains.
Click here to see the new crisis that could abruptly end this current bull market.

SEC Filings (Institutional Ownership Changes) for Alnylam Pharmaceuticals (NASDAQ:ALNY)

92.97% of Alnylam Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ALNY by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Alnylam Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/25/2024Tidal Investments LLC20,544$5.65M0.1%+75.1%0.016%Search for SEC Filing on Google Icon
11/25/2024Sanctuary Advisors LLC4,558$1.25M0.0%+91.8%0.004%Search for SEC Filing on Google Icon
11/18/2024Teachers Retirement System of The State of Kentucky34,713$9.55M0.1%+4.5%0.027%Search for SEC Filing on Google Icon
11/18/2024Toronto Dominion Bank15,466$4.25M0.0%+27.3%0.012%Search for SEC Filing on Google Icon
11/18/2024Coldstream Capital Management Inc.1,211$0.33M0.0%+43.7%0.001%Search for SEC Filing on Google Icon
11/18/2024Orion Capital Management LLC3,425$0.94M0.5%-4.2%0.003%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC2,147,203$589.21M0.0%+3.2%1.665%Search for SEC Filing on Google Icon
11/15/2024Prestige Wealth Management Group LLC451$0.12M0.0%+65.8%0.000%Search for SEC Filing on Google Icon
11/15/2024Vestcor Inc2,458$0.68M0.0%+20.6%0.002%Search for SEC Filing on Google Icon
11/15/2024Public Employees Retirement System of Ohio48,437$13.32M0.1%-6.3%0.038%Search for SEC Filing on Google Icon
11/15/2024Groupama Asset Managment1,521,385$0.42M0.0%-0.2%1.180%Search for SEC Filing on Google Icon
11/15/2024Nomura Asset Management Co. Ltd.85,445$23.50M0.1%+7.8%0.066%Search for SEC Filing on Google Icon
11/15/2024MML Investors Services LLC3,086$0.85M0.0%+5.7%0.002%Search for SEC Filing on Google Icon
11/15/2024Orion Portfolio Solutions LLC3,541$0.97M0.0%+14.8%0.003%Search for SEC Filing on Google Icon
11/15/2024EP Wealth Advisors LLC732$0.20M0.0%N/A0.001%Search for SEC Filing on Google Icon
11/15/2024Kovitz Investment Group Partners LLC2,431$0.67M0.0%N/A0.002%Search for SEC Filing on Google Icon
11/15/2024Worldquant Millennium Advisors LLC58,520$16.10M0.1%-54.8%0.045%Search for SEC Filing on Google Icon
11/15/2024Two Sigma Advisers LP103,100$28.36M0.1%-60.1%0.080%Search for SEC Filing on Google Icon
11/15/2024Sphera Funds Management LTD.7,000$1.93M0.3%N/A0.005%Search for SEC Filing on Google Icon
11/15/2024Stifel Financial Corp5,830$1.60M0.0%-1.8%0.005%Search for SEC Filing on Google Icon
11/15/2024SYM FINANCIAL Corp947$0.26M0.0%+6.2%0.001%Search for SEC Filing on Google Icon
11/15/2024Quantinno Capital Management LP3,366$0.93M0.0%+50.3%0.003%Search for SEC Filing on Google Icon
11/15/2024Royal London Asset Management Ltd.279,750$76.94M0.2%-0.9%0.217%Search for SEC Filing on Google Icon
11/15/2024Polar Asset Management Partners Inc.5,900$1.62M0.0%-41.0%0.005%Search for SEC Filing on Google Icon
11/15/2024Parkman Healthcare Partners LLC25,485$7.01M0.9%N/A0.020%Search for SEC Filing on Google Icon
11/15/2024Motley Fool Asset Management LLC1,760$0.49M0.0%-6.9%0.001%Search for SEC Filing on Google Icon
11/15/2024Ikarian Capital LLC8,741$2.40M0.3%N/A0.007%Search for SEC Filing on Google Icon
11/15/2024Investment Management Corp of Ontario7,059$1.94M0.0%+153.5%0.005%Search for SEC Filing on Google Icon
11/15/2024Janus Henderson Group PLC219,337$60.32M0.0%-12.1%0.170%Search for SEC Filing on Google Icon
11/15/2024HighTower Advisors LLC115,790$31.93M0.0%-7.4%0.090%Search for SEC Filing on Google Icon
11/15/2024HighVista Strategies LLC1,551$0.43M0.1%-40.4%0.001%Search for SEC Filing on Google Icon
11/15/2024Beacon Investment Advisory Services Inc.4,401$1.21M0.1%-5.1%0.003%Search for SEC Filing on Google Icon
11/15/2024Erste Asset Management GmbH16,510$4.54M0.1%N/A0.013%Search for SEC Filing on Google Icon
11/15/2024True Wealth Design LLC154$42K0.0%+15,300.0%0.000%Search for SEC Filing on Google Icon
11/14/2024Bellevue Group AG809,095$222.53M3.6%-12.0%0.627%Search for SEC Filing on Google Icon
11/14/2024BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp21,108$5.81M0.0%-12.8%0.016%Search for SEC Filing on Google Icon
11/14/2024PDT Partners LLC3,484$0.96M0.1%-75.6%0.003%Search for SEC Filing on Google Icon
11/14/2024Eventide Asset Management LLC224,333$61.70M1.1%+157.9%0.174%Search for SEC Filing on Google Icon
11/14/2024Captrust Financial Advisors4,833$1.33M0.0%+34.4%0.004%Search for SEC Filing on Google Icon
11/14/2024Suvretta Capital Management LLC13,824$3.80M0.1%-63.3%0.011%Search for SEC Filing on Google Icon
11/14/2024MetLife Investment Management LLC7,318$2.01M0.0%-1.9%0.006%Search for SEC Filing on Google Icon
11/14/2024Blueshift Asset Management LLC1,067$0.29M0.1%N/A0.001%Search for SEC Filing on Google Icon
11/13/2024Bridgewater Associates LP2,002$0.55M0.0%N/A0.002%Search for SEC Filing on Google Icon
11/13/2024Freedom Investment Management Inc.1,159$0.32M0.0%-9.8%0.001%Search for SEC Filing on Google Icon
11/13/2024Brooklyn Investment Group413$0.11M0.0%N/A0.000%Search for SEC Filing on Google Icon
11/13/2024Quantbot Technologies LP204$56K0.0%+1,754.5%0.000%Search for SEC Filing on Google Icon
11/13/2024Dai ichi Life Insurance Company Ltd955$0.26M0.0%-11.3%0.001%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company 191,382$52.64M0.0%-41.8%0.148%Search for SEC Filing on Google Icon
11/13/2024Horizon Kinetics Asset Management LLC2,759$0.76M0.0%-4.2%0.002%Search for SEC Filing on Google Icon
11/13/2024Loomis Sayles & Co. L P525,303$144.47M0.2%-7.7%0.407%Search for SEC Filing on Google Icon
11/13/2024Harvest Fund Management Co. Ltd162$45K0.0%N/A0.000%Search for SEC Filing on Google Icon
11/13/2024Daiwa Securities Group Inc.12,072$3.32M0.0%+6.9%0.009%Search for SEC Filing on Google Icon
11/12/2024Swedbank AB53,729$14.78M0.0%+160.3%0.042%Search for SEC Filing on Google Icon
11/12/2024Penserra Capital Management LLC2,413$0.66M0.0%-77.7%0.002%Search for SEC Filing on Google Icon
11/12/2024Algert Global LLC9,825$2.70M0.1%+401.3%0.008%Search for SEC Filing on Google Icon
11/12/2024Cerity Partners LLC13,019$3.58M0.0%+133.6%0.010%Search for SEC Filing on Google Icon
11/12/2024Telemark Asset Management LLC100,000$27.50M2.8%N/A0.078%Search for SEC Filing on Google Icon
11/12/2024Eagle Asset Management Inc.309,589$85.89M0.5%+25.7%0.240%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.487,348$134.04M0.0%+3.6%0.378%Search for SEC Filing on Google Icon
11/8/2024Grandfield & Dodd LLC1,224$0.34M0.0%N/A0.001%Search for SEC Filing on Google Icon
11/8/2024Advisors Asset Management Inc.4,767$1.31M0.0%+4.1%0.004%Search for SEC Filing on Google Icon
11/8/2024Connor Clark & Lunn Investment Management Ltd.73,320$20.17M0.1%+22.4%0.057%Search for SEC Filing on Google Icon
11/8/2024Commerce Bank4,522$1.24M0.0%-2.1%0.004%Search for SEC Filing on Google Icon
11/8/2024PNC Financial Services Group Inc.12,543$3.45M0.0%+1.2%0.010%Search for SEC Filing on Google Icon
11/8/2024B. Metzler seel. Sohn & Co. Holding AG3,279$0.90M0.0%N/A0.003%Search for SEC Filing on Google Icon
11/8/2024Banque Cantonale Vaudoise5,560$1.53M0.1%N/A0.004%Search for SEC Filing on Google Icon
11/8/2024Spectrum Planning & Advisory Services Inc.3,359$0.92M0.9%-5.6%0.003%Search for SEC Filing on Google Icon
11/7/2024Pathstone Holdings LLC6,249$1.72M0.0%+11.2%0.005%Search for SEC Filing on Google Icon
11/7/2024Nixon Peabody Trust Co.2,250$0.62M0.1%-31.8%0.002%Search for SEC Filing on Google Icon
11/7/2024LMR Partners LLP67,489$18.56M0.1%-39.2%0.052%Search for SEC Filing on Google Icon
11/7/2024TrinityPoint Wealth LLC728$0.20M0.0%N/A0.001%Search for SEC Filing on Google Icon
11/7/2024Gilbert & Cook Inc.3,924$1.08M0.1%-3.4%0.003%Search for SEC Filing on Google Icon
11/7/2024Swiss National Bank375,400$103.25M0.1%+0.3%0.291%Search for SEC Filing on Google Icon
11/6/2024Mutual of America Capital Management LLC1,924$0.53M0.0%+26.7%0.001%Search for SEC Filing on Google Icon
11/6/2024Natixis Advisors LLC10,002$2.75M0.0%N/A0.008%Search for SEC Filing on Google Icon
11/6/2024Empowered Funds LLC7,064$1.94M0.0%+315.0%0.005%Search for SEC Filing on Google Icon
11/6/2024CIBC Asset Management Inc4,483$1.23M0.0%+5.5%0.003%Search for SEC Filing on Google Icon
11/6/2024OneDigital Investment Advisors LLC1,021$0.28M0.0%N/A0.001%Search for SEC Filing on Google Icon
11/6/2024Metis Global Partners LLC4,380$1.21M0.0%+47.2%0.003%Search for SEC Filing on Google Icon
11/6/2024Zions Bancorporation N.A.592$0.16M0.0%+2,860.0%0.000%Search for SEC Filing on Google Icon
11/6/2024Huntington National Bank94$26K0.0%+91.8%0.000%Search for SEC Filing on Google Icon
11/6/2024Plato Investment Management Ltd4,702$1.29M0.1%+33.2%0.004%Search for SEC Filing on Google Icon
11/6/2024Oppenheimer & Co. Inc.1,906$0.52M0.0%+11.1%0.001%Search for SEC Filing on Google Icon
11/5/2024Souders Financial Advisors3,353$0.92M0.1%-4.5%0.003%Search for SEC Filing on Google Icon
11/5/2024Victory Capital Management Inc.42,909$11.80M0.0%+10.9%0.033%Search for SEC Filing on Google Icon
11/5/2024Sumitomo Mitsui Trust Group Inc.278,241$76.53M0.1%+0.5%0.216%Search for SEC Filing on Google Icon
11/5/2024Baillie Gifford & Co.4,887,000$1.34B1.0%-19.0%3.789%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP2,860$0.79M0.1%+55.3%0.002%Search for SEC Filing on Google Icon
11/4/2024Los Angeles Capital Management LLC137,017$37.68M0.2%+11,433.4%0.107%Search for SEC Filing on Google Icon
11/4/2024State of New Jersey Common Pension Fund D47,433$13.05M0.1%-2.1%0.037%Search for SEC Filing on Google Icon
11/2/2024Covestor Ltd457$0.13M0.1%-41.1%0.000%Search for SEC Filing on Google Icon
11/1/2024Proficio Capital Partners LLC744$0.21M0.0%-53.0%0.001%Search for SEC Filing on Google Icon
11/1/2024Atria Investments Inc3,145$0.87M0.0%+78.9%0.002%Search for SEC Filing on Google Icon
11/1/2024Lindbrook Capital LLC570$0.16M0.0%+11.1%0.000%Search for SEC Filing on Google Icon
11/1/2024Assetmark Inc.9,186$2.53M0.0%+8.2%0.007%Search for SEC Filing on Google Icon
11/1/2024Washington Trust Advisors Inc.152$42K0.0%N/A0.000%Search for SEC Filing on Google Icon
11/1/2024Hollencrest Capital Management105$29K0.0%N/A0.000%Search for SEC Filing on Google Icon
11/1/2024Capital Performance Advisors LLP440$0.12M0.0%N/A0.000%Search for SEC Filing on Google Icon
11/1/2024AIA Group Ltd28,217$7.76M0.2%+45.2%0.022%Search for SEC Filing on Google Icon
10/31/2024Principal Financial Group Inc.10,608$2.92M0.0%-25.2%0.008%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Alnylam Pharmaceuticals logo
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. In addition, the company develops patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; Belcesiran for the treatment of alpha-1 liver disease; Elebsiran to treat chronic HBV infection; Zilebesiran to treat hypertension; ALN-APP to treat Alzheimer's disease and cerebral amyloid angiopathy; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Roche to develop pharmaceutical products containing zilebesiran. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Read More on Alnylam Pharmaceuticals

Today's Range

Now: $250.98
Low: $247.36
High: $255.46

50 Day Range

MA: $273.13
Low: $232.27
High: $300.55

52 Week Range

Now: $250.98
Low: $141.98
High: $304.39

Volume

1,213,299 shs

Average Volume

878,164 shs

Market Capitalization

$32.37 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.39

Who are the company insiders with the largest holdings of Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals' top insider investors include:
  1. Yvonne Greenstreet (CEO)
  2. Jeffrey V Poulton (CFO)
  3. Akshay Vaishnaw (President)
  4. Michael W Bonney (Director)
  5. Pushkal Garg (CMO)
  6. Kevin Joseph Fitzgerald (EVP)
  7. Amy W Schulman (Director)
  8. Indrani Lall Franchini (EVP)
  9. Tolga Tanguler (EVP)
  10. David E I Pyott (Director)
  11. Dennis A Ausiello (Director)
Learn More about top insider investors at Alnylam Pharmaceuticals.

Who are the major institutional investors of Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals' top institutional shareholders include:
  1. Baillie Gifford & Co. — 3.79%
  2. Geode Capital Management LLC — 1.66%
  3. Groupama Asset Managment — 1.18%
  4. Bellevue Group AG — 0.63%
  5. Loomis Sayles & Co. L P — 0.41%
  6. Charles Schwab Investment Management Inc. — 0.38%
Learn More about top institutional investors of Alnylam Pharmaceuticals stock.

Which major investors are selling Alnylam Pharmaceuticals stock?

In the last quarter, ALNY stock was sold by these institutional investors:
  1. New York State Common Retirement Fund
  2. Baillie Gifford & Co.
  3. Two Sigma Advisers LP
  4. The Manufacturers Life Insurance Company
  5. Bellevue Group AG
  6. Assenagon Asset Management S.A.
  7. Worldquant Millennium Advisors LLC
  8. Citigroup Inc.
During the last year, company insiders that have sold Alnylam Pharmaceuticals company stock include:
  1. Yvonne Greenstreet (CEO)
  2. Jeffrey V Poulton (CFO)
  3. Akshay Vaishnaw (President)
  4. Michael W Bonney (Director)
  5. Pushkal Garg (CMO)
  6. Kevin Joseph Fitzgerald (EVP)
  7. Amy W Schulman (Director)
  8. Indrani Lall Franchini (EVP)
Learn More investors selling Alnylam Pharmaceuticals stock.

Which major investors are buying Alnylam Pharmaceuticals stock?

In the previous quarter, ALNY stock was acquired by institutional investors including:
  1. Eventide Asset Management LLC
  2. Los Angeles Capital Management LLC
  3. Parallax Volatility Advisers L.P.
  4. Telemark Asset Management LLC
  5. Geode Capital Management LLC
  6. Eagle Asset Management Inc.
  7. Barclays PLC
  8. Swedbank AB
"This Could Be Worse Than the Great Depression, the Dot-Com Crash, and the 2008 Crisis Combined"
From Stansberry Research   |   Ad
What Are These Billionaire Investors Afraid Of? Billionaires Warren Buffett, Stanley Druckenmiller, George Soros, and David Tepper have all sold off massive U.S. stock positions, including shares of Nvidia, Apple, and Bank of America. Billionaire Ray Dalio, who runs one of the world’s most successful hedge funds, says, “Things are going to get worse for our economy.” What are these billionaires so worried about?
Click here to see why experts and insiders may be preparing for the biggest financial crisis of the